ArticleAnalytical chemistry2026
Label-Free Detection of Cellular Aβ Accumulation and Mitochondrial Dysfunction in AD Cell Models via Raman Microscopy.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease (AD) is a neurocognitive disorder characterized by the accumulation of amyloid beta (Aβ) in senile plaques in the brain. Aβ accumulates in nerve cells, causing cellular dysfunction through various mechanisms, including mitochondrial dysfunction, leading to apoptosis. AD cell models are being studied to elucidate the neurotoxic effect of Aβ; however, conventional methods such as immunostaining and fluorescent molecular labeling require extensive sample manipulation and may produce artifacts not reflective of natural states. In this study, we employed Raman microscopy on AD cell models and simultaneously detected Aβ accumulated in cells and associated mitochondrial dysfunction through cytochrome distribution changes. This label-free method enables the observation of AD cell models in a more natural state and is expected to contribute to elucidating the mechanism of cell damage caused by Aβ. Furthermore, applying this system to experiments involving Aβ inhibitor administration enables rapid, label-free evaluation of drug activity, which is highly valuable in drug development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.